GlycoMimetics Inc. Announces Annual Meeting of Stockholders on May 1, 2024

TL;DR

<b>GlycoMimetics Inc. will hold its virtual Annual Meeting of Stockholders on May 1, 2024, to vote on director elections, auditor ratification, executive compensation, and a stock increase.</b>

AI Summary

GLYCOMIMETICS INC (CBIO) filed a Proxy Statement (DEF 14A) with the SEC on April 1, 2024. Annual Meeting of Stockholders to be held virtually on May 1, 2024, at 9:00 a.m. ET. Proposes election of two director nominees for terms until the 2027 Annual Meeting. Seeks ratification of Ernst & Young LLP as independent auditor for fiscal year ending December 31, 2024. Requests advisory approval of named executive officer compensation. Proposes amendment to increase authorized common stock from 100,000,000 to 150,000,000 shares.

Why It Matters

For investors and stakeholders tracking GLYCOMIMETICS INC, this filing contains several important signals. The proposed increase in authorized shares from 100 million to 150 million could signal future financing needs or strategic initiatives requiring more capital. The company is seeking shareholder approval for executive compensation, which is a standard but important governance item that can impact employee morale and investor perception.

Risk Assessment

Risk Level: low — GLYCOMIMETICS INC shows low risk based on this filing. The filing is a routine proxy statement for an annual meeting with standard proposals, indicating no immediate high-risk events.

Analyst Insight

Stockholders should review the proposals regarding director elections, executive compensation, and the increase in authorized shares to make informed voting decisions.

Key Numbers

• May 1, 2024 — Annual Meeting Date (Annual Meeting of Stockholders)
• 2027 — Director Term End (Director nominees' term)
• December 31, 2024 — Fiscal Year End (Independent auditor's fiscal year)
• 100,000,000 — Current Authorized Shares (Common stock)
• 150,000,000 — Proposed Authorized Shares (Common stock)

Key Players & Entities

• GLYCOMIMETICS INC (company) — Registrant
• May 1, 2024 (date) — Annual Meeting of Stockholders date
• Ernst & Young LLP (company) — Independent registered public accounting firm
• December 31, 2024 (date) — Fiscal year end
• 100,000,000 (dollar_amount) — Current authorized shares of common stock
• 150,000,000 (dollar_amount) — Proposed authorized shares of common stock

FAQ

Risk Factors

• Proxy Statement Filing [low — regulatory]: The company is filing a definitive proxy statement (DEF 14A) for its annual meeting of stockholders.

Key Dates

• 2024-05-01: Annual Meeting of Stockholders — To elect directors, ratify auditor, approve compensation, and amend certificate of incorporation.

Glossary

DEF 14A

A definitive proxy statement filed with the SEC. (Indicates the filing is a formal proxy statement for shareholder voting.)

Named Executive Officers

The top executive compensation recipients at a company. (Shareholder approval of their compensation is being sought.)

Certificate of Incorporation

The foundational document of a corporation, outlining its structure and powers. (An amendment is proposed to increase authorized shares.)

Key Financial Figures

• $20,000 — lliance Advisors a fee of approximately $20,000 plus reasonable expenses for these serv

Filing Documents

• tmb-20240501xdef14a.htm (DEF 14A) — 1099KB
• tmb-20240501xdef14a_a001.jpg (GRAPHIC) — 4KB
• tmb-20240501xdef14a_a005.jpg (GRAPHIC) — 34KB
• tmb-20240501xdef14a_a006.jpg (GRAPHIC) — 32KB
• tmb-20240501xdef14a_bg001.jpg (GRAPHIC) — 126KB
• tmb-20240501xdef14a_bg002.jpg (GRAPHIC) — 102KB
• 0001558370-24-004448.txt (&nbsp;) — 1511KB

From the Filing

DEF 14A 1 tmb-20240501xdef14a.htm DEF 14A SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.__) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Pursuant to 240.14a-12 GlycoMimetics, Inc. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement if other than the Registrant) Payment of Filing Fee (Check all boxes that apply): No fee required Fee paid previously with preliminary materials Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 GLYCOMIMETICS, INC. 9708 Medical Center Drive Rockville, Maryland 20850 NOTICE OF ANNUAL MEETING OF STOCKHOLDERS To Be Held On May 1, 2024 Dear Stockholder: You are cordially invited to attend the Annual Meeting of Stockholders of GlycoMimetics, Inc., a Delaware corporation. The meeting will be held on Wednesday, May 1, 2024 at 9:00 a.m. Eastern Time. The Annual Meeting will be a virtual meeting of stockholders, which will be conducted only via a live audio webcast. A complete list of record stockholders will be available for examination on a reasonably accessible electronic network by any stockholder for any purpose germane to the Annual Meeting for a period of ten days ending on the day before the Annual Meeting date. If you would like to view the list, please email us at ir@glycomimetics.com . The meeting will be held for the following purposes: 1. To elect the Board's two nominees for director named as nominees in these proxy materials to hold office until the 2027 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal. 2. To ratify the appointment by the Audit Committee of the Board of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. 3. To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in these proxy materials. 4. To approve an amendment to the Companys amended and restated certificate of incorporation, or the Restated Certificate, to increase the authorized number of shares of common stock from 100,000,000 shares to 150,000,000 shares. 5. To approve an amendment to the Restated Certificate to reflect new Delaware law provisions regarding officer exculpation. 6. To conduct any other business properly brought before the meeting. These items of business are more fully described in the Proxy Statement accompanying these proxy materials. The Annual Meeting will be held virtually through a live webcast. Stockholders of record at the close of business on March 15, 2024 and their proxy holders will be able to attend the virtual Annual Meeting, submit questions, and vote during the live webcast by visiting www.virtualshareholdermeeting.com/GLYC2024 and entering the 16-digit Control Number included on your proxy card, voting instruction form, or in the instructions that you received via email. We encourage our stockholders to retain their control numbers from proxy cards or voting instruction forms in order to be able to access the virtual Annual Meeting. Please refer to the additional logistical details and recommendations in the accompanying proxy statement. You may log in beginning at 8:30 a.m. Eastern Time on Wednesday, May 1, 2024. The record date for the Annual Meeting is March 15, 2024. Only stockholders of record at the close of business on that date and their proxy holders may vote at the meeting or any adjournment thereof. Important Notice Regarding the Availability of Proxy Materials for the Stockholders' Meeting to Be Held on May 1, 2024 at 9:00 a.m. Eastern Time at www.virtualshareholdermeeting.com/GLYC2024. The proxy statement and annual report to stockholders are available at http://materials.proxyvote.com/38000Q. By Order of the Board of Directors Christian B. Dinneen-Long Secretary Rockville, Maryland April 1, 2024 You are cordially invited to attend the meeting online. Whether or not you expect to attend the meeting, please vote over the telephone or on the Internet as instructed in these materials, or, if you receive a paper proxy card by mail, by completing and returning the enclosed proxy, as promptly as possible in order to ensure your representation at the meeting. Even if you have voted by proxy, you may still vote online if you attend the meeting. GLYCOMIMETICS, INC. 9708 Medical Center Drive Rockville, Maryland 20850 PROXY STATEMENT FOR THE 2024 ANNUAL MEETING OF STOCKHOLDERS To be held on May 1, 2024 MEETING AGENDA Proposals Voting Standard Board Recommendation Election of directors named in thi

View Full Filing

View this DEF 14A filing on SEC EDGAR